Additionally, our findings indicated that p53 rs1042522 polymorphism significantly influenced cervical cancer risk in both matched and control subgroups, suggesting that matching factors and control variables did not affect its association with cervical cancer. The gene discussed is TP53; the disease is cervical carcinoma.